Cryotherapy is a modern-day treatment wherein the body is subjected to extremely cold temperatures for several minutes. You can just get one part of your body exposed to (localised cryotherapy) and opt for whole-body cryotherapy. The first can be done in several ways like through ice packs, ice massages, coolant sprays, ice baths and even through probes administrated into tissue. A lesser-known fact is that the use of low temperature in healing dates back to 2500 BC. However, it only came into modern practice after being used by Japanese doctor Yamaguchi in 1978 to treat people with rheumatoid arthritis.

How Does This Treatment Work?

The theory for whole-body cryotherapy (WBC) is that by immersing the body in extremely cold air for several minutes, you could receive a number of health benefits. Throughout the process, the individual stands in an enclosed chamber or a small enclosure that surrounds their body but has an opening for their head at the top. The temperature in the enclosure drops to between negative 200–300°F. The person stays in the ultra-low temperature air for between two and four minutes.

You can get benefits from just one session of cryotherapy but it is most effective when used regularly. There are many athletes who do this regularly, some athletes use cryotherapy two times every day and others will go daily for 10 days and then once a month afterwards.

Key Benefits Of Cryotherapy

1. Relieves Migraine Symptoms: Cooling the neck's carotid arteries helps reduce pain by cooling blood in intracranial vessels.

2. Eases Nerve Pain: Cryotherapy numbs irritated nerves, aiding in the treatment of pinched nerves, chronic pain, and acute injuries.

3. Improves Mood: By triggering hormonal releases like endorphins, it may help alleviate anxiety and depression.

4. Reduces Arthritic Pain: Whole-body cryotherapy can minimize arthritis pain and enhance rehabilitation.

5. Aids Cancer Treatment: Targeted cryotherapy ("cryosurgery") freezes and kills cancer cells in low-risk tumours, like prostate cancer.

6. Supports Cognitive Health: Its anti-inflammatory effects may prevent Alzheimer’s and dementia, though research is ongoing.

7. Treats Skin Conditions: Conditions like atopic dermatitis and acne may benefit from reduced inflammation and improved antioxidant levels.

What Are The Risks Of This Treatment?

Cryotherapy has a beneficial impact on your mental health too. Experts say that cryotherapy has the potential to effectively treat stress disorders like general anxiety, depression Post-traumatic Stress Disorder (PTSD), and Obsessive Compulsive Disorder (OCD.)

A 2012 study also suggested that cryotherapy can mitigate inflammation and oxidative stress, which is linked to dementia, mild cognitive impairment other age-related cognitive decline. Another study conducted in 2008 found that cryotherapy reduced symptoms by at least 50% in one-third of individuals with depression or anxiety.

Nipah virus, first identified in 1999, is a serious threat that is 'underestimated' and with its repeated emergence in South and Southeast Asia, it has the potential to turn 'more severe', according to a global team of scientists.

Nipah virus is a zoonotic virus, usually transmitted from animals to humans, but can also be transmitted through contaminated food or directly between people.

In a correspondence published in The Lancet, the scientific team led by the Campus Bio-Medico University of Rome in Italy stated: “the danger of the Nipah virus is in its persistence, that is, it is periodic, lethal, and preventable".

The researchers argued that although the Nipah virus is well understood, there is little action on it, with delays in surveillance, sporadic funding, and episodic preparedness.

“How South and Southeast Asia respond now will determine whether the Nipah virus remains a regional epidemic or if it escalates into something far more severe,” said the experts.

Also read: Why The Nipah Virus Still Persists After 25 Years In Southeast Asia

Recent Nipah Outbreaks In India

According to the Ministry of Health & Family Welfare, two cases of the deadly Nipah virus Disease (NiVD) -- a male nurse from Purba Medinipur district and a female nurse from Mongolkot in Purba Bardhaman district who worked at a private hospital in Barasat in North 24 Parganas district -- were confirmed in West Bengal since last December.

Of these, the 25-year-old female nurse died of cardiac arrest after recovering from Nipah virus infection.

"She died of cardiac arrest this afternoon. Though she had recovered from Nipah infection, she was suffering from multiple complications," a state health department official told PTI in February. The male nurse had recovered and returned home.

Nipah has been endemic to both West Bengal and Keralam (formerly known as Kerala).

The first recorded Nipah outbreak in India occurred in 2001 in West Bengal’s Siliguri, where about 66 cases were reported with high fatality, with significant hospital-based transmission among healthcare workers. Again in 2007, the eastern state’s Nadia district reported an outbreak.

Keralam reported its first Nipah virus outbreak in 2018. The state’s northern districts, Kozhikode and Malappuram, have been on high alert with sporadic and periodic cases occurring in the state in 2019, 2021, 2023, 2024, and 2025.

These cases “are not anomalies and are a reminder of a virus causing recurrent outbreaks for more than two decades, with high mortality, frequent infections of health-care workers, and no approved vaccines or treatments,” said the scientists in the Lancet Correspondence.

Also read: These 24 Pathogens Could Trigger The Next Pandemic, Says UKHSA

What Is The Nipah Virus? How To Prevent?

Nipah is essentially a zoonotic infection -- from animals to humans -- and then from human to human.

The Nipah virus spreads through

• saliva,
• urine,
• other body fluids of an infected person.

The Nipah virus, although rare, is unpredictable. It is not limited to just one part of the body. In severe cases, it can affect multiple organs.

The Lancet paper also highlighted the "lack of diagnostics, protective equipment, and trained personnel" in many facilities in rural and peri-urban areas.

• The researchers suggested
• prioritizing sustained investment
• boosting surveillance,
• improving infection prevention and control,
• decentralizing laboratory capacity,
• One Health implementation,
• regional data sharing,
• accelerated development of vaccines and therapeutics.

“Viruses do not depend on political visibility or public concern to spread; transmission occurs when ecological disruption, delayed detection, and health-system susceptibilities converge,” the experts said.

A new, highly mutated COVID variant called 'Cicada' is spreading in the US. This is the BA.3.2 mutation of the COVID-19 variant. While nationally the cases of COVID have remained low, the BA.3.2 strain is gaining traction across the globe.

What Is The Cicada COVID Variant?

Cicada or the BA.3.2 strain emerged over a year ago, and simmered until last fall. However, this was when it started ramping up in countries including the US. As of February, BA.3.2 has been detected in at least 25 states, noted the US Centers for Disease Control and Prevention (CDC).

The variant's slew of genetic changes in its spike protein is what has made people concerned. This is what makes it unique and distinct from other variants in circulation.

According to Andrew Pekosz, Ph.D., a virologist at the Johns Hopkins Bloomberg School of Public Health, as reported by TODAY.com, "It [the variant] has a lot of mutations that may cause it to look different to your immune system."

The SARS-CoV-2 virus that causes COVID-19 mutates constantly and spreads over time. It thus leads to emergence of new variants.

A new study published in the CDC’s Morbidity and Mortality Weekly Report suggests that emerging variants could weaken protection gained from prior COVID-19 infection or vaccination.

One such “hyper-mutated” strain, BA.3.2, is now being closely tracked by public health officials. In December 2025, the World Health Organization classified it as a “variant under monitoring.”

Read: COVID Variant BA.3.2 Spreads To 23 Countries: Is The Variant Under Monitoring A Cause Of Worry?

When Was Cicada COVID Variant First Detected?

BA.3.2 was first detected in South Africa in November 2024. It is a descendant of BA.3, an Omicron subvariant that appeared in 2022 and briefly circulated alongside BA.1 and BA.2, according to the CDC.

Although BA.3 never became dominant, it did not completely disappear. “It fizzled out, but persisted at low levels,” said Pekosz. After two years and dozens of mutations, BA.3.2 eventually emerged.

For much of 2024, the variant spread quietly, overshadowed by dominant strains like Nimbus and XFG, which stem from BA.2. However, by September, BA.3.2 began gaining ground. “It was under the radar, replicating, until it started spreading more efficiently between people,” Pekosz noted.

What sets BA.3.2 apart is its spike protein, which carries an unusually high number of mutations — around 70 to 75. This makes it significantly different from strains such as JN.1 and LP.8.1, which current COVID-19 vaccines are designed to target.

The CDC describes BA.3.2 as a “genetically distinct” lineage compared to recent variants. Early laboratory studies suggest it may be capable of evading existing immunity, as its spike protein changes help it escape neutralising antibodies.

What Makes Cicada So Unique?

The BA.3.2 variant is nicknamed by T Ryan Gregory, Ph.D., a professor of evolutionary biology at the University of Guelph. He wrote on X, formerly Twitter: "Well, it's that time again. Meet "Cicada", BA.3.2* (including descendant RE.*). This one has been underground for years (its ancestor BA.3 hasn't been circulating since early 2022, and didn't do much then either) but is now emerging as a contender for the next major lineage."

While most of the symptoms of this new variant remains same as from the other variants, one thing that stands out here is the gastrointestinal symptoms that cicada could cause. However, experts note that this variant will not make anyone more sicker. Other symptoms include:

• Cough
• Fever or chills
• Sore throat
• Congestion
• Shortness of breath
• Loss of smell or taste
• Fatigue
• Headache

On March 13, the Ministry of Social Justice and Empowerment introduced the Transgender Persons (Protection of Rights) Amendment Bill, 2026, in the Lok Sabha. Amid opposition, the Rajya Sabha gave its not to the Bill on March 25. The bill seeks to amend the Transgender Persons (Protection of Rights) Amendment Act 2019. The bill was passed in the Lok Sabha on March 24.

What Makes The Bill So Controversial?

What the law originally promised: India's legal framework for transgenders rights comes from the landmark NALSA v. Union of India ruling. This is where the Supreme Court recognized transgender persons as 'third gender' and affirmed their fundamental rights, including access to healthcare. The 2019 amendment followed and promised non-discrimination in education employment, housing, and crucially, healthcare. As per a Live Law analysis, the law was intended to align with constitutional guarantees of equality and dignity, especially under Article 14 (Equality Before Law), 15 (Prohibition of Discrimination), and 21 (Right To Life).

Recent amendments have however raised concerns because of how it could reshape access to healthcare and recognition of identity.

What Does The New Bill Introduce?

The Bill introduces stricter verification of identification and tightens the definition of transgender identity by replacing self-identification with mandatory medical certification. This, many argue is against the 2019 Act supported by the NALSA judgment.

'We, the transgender people of India, reject the erasure of our identity," writes Dr Aqsa Shaikh for the media outlet - The Indian Express. One of the biggest concerns she and many pointed was the continued requirement of official certification for gender identity.

While the law does not always explicitly mandate surgery, activists argue that in practice, access to updated identity documents often becomes tied to medical procedures.

This creates barriers to gender-affirming healthcare, which includes hormone therapy, surgeries, and mental health support.

Dr Shaikh, who is a transgender professor at the Department of Community Medicine in Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, argues that such provisions undermine the principle of self-identification, which was central to the NALSA judgment.

Gaps In Gender-Affirming Healthcare Access

Experts have long pointed out that transgender healthcare in India is already limited:

• Few public hospitals offer structured gender-affirming services
• Mental health support tailored to transgender individuals remains scarce
• Hormone therapy is often accessed informally without supervision

Critics also argue that the amendments do little to expand healthcare infrastructure, focusing instead on administrative control.

Health activists have also flagged the absence of:

• Universal insurance coverage for gender-affirming procedures
• Clear funding commitments for public healthcare services
• Standardized treatment protocols across states

This is significant because transgender individuals face disproportionately high rates of:

• Depression and anxiety
• Substance use disorders
• Suicide risk

Without systemic healthcare guarantees, the law’s protections risk remaining symbolic.

Erasure Of Identity

An opinion piece in The Leaflet describes this bill as an "architecture of erasure". The piece argued that it weakens recognition of diverse transgender identities by reinforcing bureaucratic control. Dr Shaikh argues that the community rejects any framework that takes away the right to self-identify, calling it a rollback of constitutional morality.

Furthermore, a LiveMint report notes that the amendment is a "hurried, short-sighted decision" because it was passed without adequate consultation with transgender communities, it ignores lived experiences and healthcare needs, and prioritizes regulation over welfare.

Live Law notes that any law that govern transgender rights must remain consistent with the NALSA judgment. However, the recent amendment could dilute the principle supported by NALSA judgment that gender identity is based on self-perception and not state or medical approval.